Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.

Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallée VP, Hébert J, Krivstov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A.

Cancer Discov. 2018 Feb 5. pii: CD-17-1271. doi: 10.1158/2159-8290.CD-17-1271. [Epub ahead of print]

PMID:
29431698
2.

Peptidomimetic blockade of MYB in acute myeloid leukemia.

Ramaswamy K, Forbes L, Minuesa G, Gindin T, Brown F, Kharas MG, Krivtsov AV, Armstrong SA, Still E, de Stanchina E, Knoechel B, Koche R, Kentsis A.

Nat Commun. 2018 Jan 9;9(1):110. doi: 10.1038/s41467-017-02618-6.

3.

Erratum: PGBD5 promotes site-specific oncogenic mutations in human tumors.

Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A.

Nat Genet. 2017 Sep 27;49(10):1558. doi: 10.1038/ng1017-1558b. No abstract available.

PMID:
28951624
4.

PGBD5 promotes site-specific oncogenic mutations in human tumors.

Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodríguez-Fos E, Gonzalez S, Puiggròs M, Blackford AN, Mason CE, de Stanchina E, Gönen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A.

Nat Genet. 2017 Jul;49(7):1005-1014. doi: 10.1038/ng.3866. Epub 2017 May 15. Erratum in: Nat Genet. 2017 Sep 27;49(10 ):1558.

5.

Hopefully devoted to Q: targeting glutamine addiction in cancer.

Still ER, Yuneva MO.

Br J Cancer. 2017 May 23;116(11):1375-1381. doi: 10.1038/bjc.2017.113. Epub 2017 Apr 25. Review.

6.

Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia.

Brown FC, Cifani P, Drill E, He J, Still E, Zhong S, Balasubramanian S, Pavlick D, Yilmazel B, Knapp KM, Alonzo TA, Meshinchi S, Stone RM, Kornblau SM, Marcucci G, Gamis AS, Byrd JC, Gonen M, Levine RL, Kentsis A.

Br J Haematol. 2017 Jan;176(1):86-91. doi: 10.1111/bjh.14413. Epub 2016 Oct 21.

7.

Genomic DNA transposition induced by human PGBD5.

Henssen AG, Henaff E, Jiang E, Eisenberg AR, Carson JR, Villasante CM, Ray M, Still E, Burns M, Gandara J, Feschotte C, Mason CE, Kentsis A.

Elife. 2015 Sep 25;4. pii: e10565. doi: 10.7554/eLife.10565.

8.

Complete Genome of Bacillus pumilus Siphophage Riggi.

Still EL, Riggi CF, Chamakura KR, Kuty Everett GF.

Genome Announc. 2013 Dec 5;1(6). pii: e00861-13. doi: 10.1128/genomeA.00861-13.

9.

Genotype directed therapy in murine mismatch repair deficient tumors.

Kucherlapati MH, Esfahani S, Habibollahi P, Wang J, Still ER, Bronson RT, Mahmood U, Kucherlapati RS.

PLoS One. 2013 Jul 23;8(7):e68817. doi: 10.1371/journal.pone.0068817. Print 2013.

10.

Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death.

Best C, Calianese D, Szulak K, Cammarata G, Brum G, Carbone T, Still E, Higgins K, Ji F, DI W, Wanebo H, Wan Y.

Oncol Lett. 2013 Jun;5(6):1854-1858. Epub 2013 Apr 16.

11.

N-acetylcysteine potentiates doxorubicin-induced ATM and p53 activation in ovarian cancer cells.

Brum G, Carbone T, Still E, Correia V, Szulak K, Calianese D, Best C, Cammarata G, Higgins K, Ji F, Di W, Wan Y.

Int J Oncol. 2013 Jan;42(1):211-8. doi: 10.3892/ijo.2012.1680. Epub 2012 Oct 26.

12.

Gore-Tex in facial augmentations.

Still EF 2nd.

Plast Reconstr Surg. 1997 Apr;99(5):1468. No abstract available.

PMID:
9105388
13.

Effects of dexamethasone on late radiation injury following partial-body and local organ exposures.

Geraci JP, Mariano MS, Jackson KL, Taylor DA, Still ER.

Radiat Res. 1992 Jan;129(1):61-70.

PMID:
1530802
14.

Total reconstruction of a two-compartment scrotum by tissue expansion.

Still EF 2nd, Goodman RC.

Plast Reconstr Surg. 1990 May;85(5):805-7; discussion 808.

PMID:
2326365
15.

Metabolism of ingested U and Ra.

Wrenn ME, Durbin PW, Howard B, Lipsztein J, Rundo J, Still ET, Willis DL.

Health Phys. 1985 May;48(5):601-33.

PMID:
3988524
16.
17.

Acute lethality and recovery of goats after 1 MVp x-irradiation.

Taylor JF, Still ET, Page NP, Leong GF, Ainsworth EJ.

Radiat Res. 1971 Jan;45(1):110-26. No abstract available.

PMID:
5539699
18.

Acute mortality and recovery studies in burros irradiated with 1 MVP x-rays.

Still ET, Page NP, Taylor JF, Wisecup WG, Ainsworth EJ, Leong GF.

Radiat Res. 1969 Sep;39(3):580-93. No abstract available.

PMID:
5806697
19.

Hematological response in sheep given protracted exposures to 60Co gamma radiation. NRDL-TR-69-6.

Still ET, Taketa ST, Ainsworth EJ, Leong GF, Taylor JF.

Res Dev Tech Rep. 1968 Dec 20:1-20. No abstract available.

PMID:
5308056
20.

Dose rate effect on LD50-30 in mice exposed to cobalt-60 gamma irradiation. SAM-TR-68-97.

Traynor JE, Still ET.

Tech Rep SAM-TR. 1968 Oct:1-7. No abstract available.

PMID:
5309198
21.

Acute mortality and recovery studies in burros irradiated with 1Mvp x-rays. NRDL-TR-68-101.

Still ET, Page NP, Taylor JF, Wisecup WG, Ainsworth EJ, Leong GF.

Res Dev Tech Rep. 1968 Sep 16:1-24. No abstract available.

PMID:
5305445
22.

Dose-rate studies with sheep and swine. NRDL-TR-68-96.

Ainsworth EJ, Page NP, Taylor JF, Leong GF, Still ET.

Res Dev Tech Rep. 1968 Jun 3:1-42. No abstract available.

PMID:
5306311
23.

Graphic method for the determination of titration end-points.

Ingman F, Still E.

Talanta. 1966 Oct;13(10):1431-42.

PMID:
18960023
24.

Some effects of whole-body 32-Mev proton irradiations on primates.

Dalrymple GV, Lindsay IR, Ghidoni JJ, Kundel HL, Still ET, Jacobs R, Morgan IL.

Radiat Res. 1966 Jun;28(2):406-33. No abstract available.

PMID:
4957415
25.

The effect of massive doses of 32-MeV protons and Co-60 gamma radiation on serum enzyme levels of whole-body irradiated primates. SAM-TR-65-22.

Dalrymple GV, Lindsay IR, Ghidoni JJ, Kundel HL, Still ET.

Tech Rep SAM-TR. 1965 Aug:1-6. No abstract available.

PMID:
4954669
26.

Some effects of whole-body 32 MeV proton irradiation on primates. The radiations of space. II. SAM-TR-65-43.

Dalrymple GV, Lindsay IR, Ghidoni JJ, Kundel HL, Still ET, Jacobs R, Williams GH, Hall JD, Morgan IL.

Tech Rep SAM-TR. 1965 Aug:1-28. No abstract available.

PMID:
4954668
27.

Early physiologic changes in primates following mixed gamma-neutron pulsed radiation. SAM-TR-65-31.

Rice EA, Sawyer DC, Still ET, Beard SE.

Tech Rep SAM-TR. 1965 Aug:1-21. No abstract available.

PMID:
4954663
28.

The effect of massive doses of 32 MeV protons and 60-Co gamma radiation on serum enzyme levels of whole body irradiated primates.

Dalrymple GV, Lindsay IR, Ghidoni JJ, Kundel HL, Still ET.

J Nucl Med. 1965 Aug;6(8):588-93. No abstract available.

29.

On the Metabolism of the Pancreas.

Still EU.

Proc Natl Acad Sci U S A. 1933 Jan;19(1):155-7. No abstract available.

Supplemental Content

Support Center